Transposable element-driven transcript diversification and its relevance to genetic disorders

Gene

Volumn 558, Issue 2, 2015, Pages 187-194

  Ayarpadikannan, Selvam ^a   Lee, Hee Eun ^a   Han, Kyudong ^b   Kim, Heui Soo ^a  

^a Pusan National University   (South Korea)

^b Dankook University   (South Korea)

Author keywords

Alternative splicing; Antisense oligonucleotides; Exonization; Genetic disorder; Intron retention; Polyadenylation; Transposable elements

Indexed keywords

ADENOSINE DEAMINASE; ALPHA GALACTOSIDASE; APC PROTEIN; AROMATASE; BLOOD CLOTTING FACTOR 8; BRCA2 PROTEIN; COLLAGEN TYPE 4; FAS ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; MESSENGER RNA; PYRUVATE DEHYDROGENASE COMPLEX; TRANSCRIPTOME; TRANSPOSON;

ACROCEPHALOSYNDACTYLY; ALPORT SYNDROME; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; AUTOSOMAL DOMINANT OPTIC ATROPHY; BREAST CANCER; CHRONIC GRANULOMATOUS DISEASE; COFFIN LOWRY SYNDROME; DEGENERATIVE DISEASE; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DUCHENNE MUSCULAR DYSTROPHY; EXON SKIPPING; FABRY DISEASE; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; GENETIC DISORDER; GRANULOMATOSIS; HEARING IMPAIRMENT; HEMOPHILIA A; HIRSCHSPRUNG DISEASE; HOMINID; HUMAN; HUMAN GENOME; HYPERPHENYLALANINEMIA; INTRON RETENTION; MCKUSICK KAUFMAN SYNDROME; MUCOPOLYSACCHARIDOSIS TYPE 7; NEOPLASM; NEUROFIBROMATOSIS; POLYADENYLATION; PREECLAMPSIA; PRIORITY JOURNAL; PROMOTER REGION; PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY; RETINITIS PIGMENTOSA; REVIEW; SANDHOFF DISEASE; TRANSPOSON; ALTERNATIVE RNA SPLICING; GENETIC VARIABILITY; GENETICS; PHYSIOLOGY;

HOMINIDAE; PRIMATES;

ALTERNATIVE SPLICING; DNA TRANSPOSABLE ELEMENTS; GENETIC DISEASES, INBORN; GENETIC VARIATION; HUMANS; POLYADENYLATION; PROMOTER REGIONS, GENETIC; TRANSCRIPTOME;

EID: 84922237555     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.01.039     Document Type: Review

References (144)

1. Alekseyenko A.V., Kim N., Lee C.J. Global analysis of exon creation versus loss and the role of alternative splicing in 17 vertebrate genomes. RNA 2007, 13(5):661-670.
2. Amit M., et al. Biased exonization of transposed elements in duplicated genes: a lesson from the TIF-IA gene. BMC Mol. Biol. 2007, 8:109.
3. Andreassen R. Alu elements in the human genome. Tidsskr. Nor. Laegeforen. 2004, 124(18):2345-2349.
4. Ast G. How did alternative splicing evolve?. Nat. Rev. Genet. 2004, 5(10):773-782.
5. Bae M.I., et al. A new exon derived from a mammalian apparent LTR retrotransposon of the SUPT16H gene. Int. J. Genomics 2013, 10.1155/2013/387594.
6. Baek D., et al. Characterization and predictive discovery of evolutionarily conserved mammalian alternative promoters. Genome Res. 2007, 17(2):145-155.
7. Bailey J.A., Liu G., Eichler E.E. An Alu transposition model for the origin and expansion of human segmental duplications. Am. J. Hum. Genet. 2003, 73(4):823-834.
8. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 2002, 71:817-846.
9. Baust C., et al. HERV-K-T47D-related long terminal repeats mediate polyadenylation of cellular transcripts. Genomics 2000, 66(1):98-103.
10. Beck C.R., et al. LINE-1 elements in structural variation and disease. Annu. Rev. Genomics Hum. Genet. 2011, 12:187-215.
11. Belancio V.P., Roy-Engel A.M., Deininger P. The impact of multiple splice sites in human L1 elements. Gene 2008, 411(1-2):38-45.
12. Berget S.M. Exon recognition in vertebrate splicing. J. Biol. Chem. 1995, 270(6):2411-2414.
13. Bieche I., et al. Placenta-specific INSL4 expression is mediated by a human endogenous retrovirus element. Biol. Reprod. 2003, 68(4):1422-1429.
14. Biemont C., Vieira C. Genetics - junk DNA as an evolutionary force. Nature 2006, 443(7111):521-524.
15. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16(1):6-21.
16. Britten R. Transposable elements have contributed to thousands of human proteins. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(6):1798-1803.
17. Brosius J. Genomes were forged by massive bombardments with retroelements and retrosequences. Genetica 1999, 107(1-3):209-238.
18. Brosius J., Gould S.J. On "genomenclature": a comprehensive (and respectful) taxonomy for pseudogenes and other "junk DNA". Proc. Natl. Acad. Sci. U. S. A. 1992, 89(22):10706-10710.
19. Callinan P.A., Batzer M.A. Retrotransposable elements and human disease. Genome Dyn. 2006, 1:104-115.
20. Carlton V.E.H., et al. Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat. Genet. 2003, 34(1):91-96.
21. Chen C.J., Ara T., Gautheret D. Using Alu elements as polyadenylation sites: a case of retroposon exaptation. Mol. Biol. Evol. 2009, 26(2):327-334.
22. Cheung Y.F., et al. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6). J. Pharmacol. Exp. Ther. 2007, 322(2):600-609.
23. Conley A., Hinshelwood M. Mammalian aromatases. Reproduction 2001, 121(5):685-695.
24. Conley A.B., Piriyapongsa J., Jordan I.K. Retroviral promoters in the human genome. Bioinformatics 2008, 24(14):1563-1567.
25. Cooper S.J., et al. Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome. Genome Res. 2006, 16(1):1-10.
26. Cordaux R., Batzer M.A. The impact of retrotransposons on human genome evolution. Nat. Rev. Genet. 2009, 10(10):691-703.
27. Crooke S.T. Progress in antisense technology. Annu. Rev. Med. 2004, 55:61-95.
28. Cruickshanks H.A., Tufarelli C. Isolation of cancer-specific chimeric transcripts induced by hypomethylation of the LINE-1 antisense promoter. Genomics 2009, 94(6):397-406.
29. de Koning A.P.J., et al. Repetitive elements may comprise over two-thirds of the human genome. PLoS Genet. 2011, 7(12).
30. de Souza F.S.J., Franchini L.F., Rubinstein M. Exaptation of transposable elements into novel cis-regulatory elements: is the evidence always strong?. Mol. Biol. Evol. 2013, 30(6):1239-1251.
31. Deininger P. Alu elements: know the SINEs. Genome Biol. 2011, 12(12):236.
32. Deininger P.L., Batzer M.A. Alu repeats and human disease. Mol. Genet. Metab. 1999, 67(3):183-193.
33. Dias N., Stein C.A. Antisense oligonucleotides: basic concepts and mechanisms. Mol. Cancer Ther. 2002, 1(5):347-355.
34. Druker R., Whitelaw E. Retrotransposon-derived elements in the mammalian genome: a potential source of disease. J. Inherit. Metab. Dis. 2004, 27(3):319-330.
35. Edenberg H.J. Regulation of the mammalian alcohol dehydrogenase genes. Prog. Nucleic Acid Res. Mol. Biol. 2000, 64:295-341.
36. Faulkner G.J., et al. The regulated retrotransposon transcriptome of mammalian cells. Nat. Genet. 2009, 41(5):563-571.
37. Fontanella B., Russolillo G., Meroni G. MID1 mutations in patients with X-linked Opitz G/BBB syndrome. Hum. Mutat. 2008, 29(5):584-594.
38. Gaildrat P., et al. The BRCA1 c.5434C->G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements. J. Med. Genet. 2010, 47(6):398-403.
39. Galante P.A.F., et al. Detection and evaluation of intron retention events in the human transcriptome. RNA 2004, 10(5):757-765.
40. Gallus G.N., et al. Alu-element insertion in an OPA1 intron sequence associated with autosomal dominant optic atrophy. Mol. Vis. 2010, 16(22-26):178-183.
41. Ganguly A., et al. Exon skipping caused by an intronic insertion of a young Alu Yb9 element leads to severe hemophilia A. Hum. Genet. 2003, 113(4):348-352.
42. Gogvadze E., Buzdin A. Retroelements and their impact on genome evolution and functioning. Cell. Mol. Life Sci. 2009, 66(23):3727-3742.
43. Goodall G.J., Filipowicz W. Different effects of intron nucleotide composition and secondary structure on pre-mRNA splicing in monocot and dicot plants. EMBO J. 1991, 10(9):2635-2644.
44. Guipponi M., Antonarakis S.E., Scott H.S. TMPRSS3, a type II transmembrane serine protease mutated in non-syndromic autosomal recessive deafness. Front. Biosci. Landmark 2008, 13:1557-1567.
45. Han J.S., Szak S.T., Boeke J.D. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 2004, 429(6989):268-274.
46. Harduin-Lepers A., et al. The human sialyltransferase family. Biochimie 2001, 83(8):727-737.
47. Hassan R., Ho M. Mesothelin targeted cancer immunotherapy. Eur. J. Cancer 2008, 44(1):46-53.
48. Heinzen E.L., et al. Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol. 2008, 6(12):2869-2879.
49. Helderman-van den Enden A.T.J.M., et al. Becker muscular dystrophy patients with deletions around exon 51; a promising outlook for exon skipping therapy in Duchenne patients. Neuromuscul. Disord. 2010, 20(4):251-254.
50. Hughes J.F., Coffin J.M. Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution. Nat. Genet. 2001, 29(4):487-489.
51. Huh J.W., et al. Transcriptional regulation of GSDML gene by antisense-oriented HERV-H LTR element. Arch. Virol. 2008, 153(6):1201-1205.
52. Huh J.W., et al. Gain of new exons and promoters by lineage-specific transposable elements-integration and conservation event on CHRM3 gene. Mol. Cells 2009, 28(2):111-117.
53. Iwashita S., et al. A transposable element-mediated gene divergence that directly produces a novel type bovine Bcnt protein including the endonuclease domain of RTE-1. Mol. Biol. Evol. 2003, 20(9):1556-1563.
54. Janicic N., et al. Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am. J. Hum. Genet. 1995, 56(4):880-886.
55. Jern P., Coffin J.M. Effects of retroviruses on host genome function. Annu. Rev. Genet. 2008, 42:709-732.
56. Jin D.Y., et al. Mitotic checkpoint locus MAD1L1 maps to human chromosome 7p22 and mouse chromosome 5. Genomics 1999, 55(3):363-364.
57. Karimi M.M., et al. DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs. Cell Stem Cell 2011, 8(6):676-687.
58. Kazazian H.H. Mobile elements: drivers of genome evolution. Science 2004, 303(5664):1626-1632.
59. Kim H.S. Genomic impact, chromosomal distribution and transcriptional regulation of HERV elements. Mol. Cells 2012, 33(6):539-544.
60. Kim E., Goren A., Ast G. Alternative splicing: current perspectives. Bioessays 2008, 30(1):38-47.
61. Kimura K., et al. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res. 2006, 16(1):55-65.
62. Kjellman C., et al. HERV-F(XA34) is a full-length human endogenous retrovirus expressed in placental and fetal tissues. Gene 1999, 239(1):99-107.
63. Kluge C., et al. Chromosomal localization, genomic structure and characterization of the human gene and a retropseudogene for 6-pyruvoyltetrahydropterin synthase. Eur. J. Biochem. 1996, 240(2):477-484.
64. Knebelmann B., et al. Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum. Mol. Genet. 1995, 4(4):675-679.
65. Kolomietz E., et al. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 2002, 35(2):97-112.
66. Kondo-Iida E., et al. Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD). Hum. Mol. Genet. 1999, 8(12):2303-2309.
67. Kornreich R., Bishop D.F., Desnick R.J. Alpha-galactosidase-a gene rearrangements causing fabry disease - identification of short direct repeats at breakpoints in an Alu-rich gene. J. Biol. Chem. 1990, 265(16):9319-9326.
68. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409(6822):860-921.
69. Lee J.Y., Ji Z., Tian B. Phylogenetic analysis of mRNA polyadenylation sites reveals a role of transposable elements in evolution of the 3'-end of genes. Nucleic Acids Res. 2008, 36(17):5581-5590.
70. Lee Y., et al. Variants affecting exon skipping contribute to complex traits. PLoS Genet. 2012, 8(10).
71. Levin H.L., Moran J.V. Dynamic interactions between transposable elements and their hosts. Nat. Rev. Genet. 2011, 12(9):615-627.
72. Lev-Maor G., et al. The birth of an alternatively spliced exon: 3' splice-site selection in Alu exons. Science 2003, 300(5623):1288-1291.
73. Lev-Maor G., et al. RNA-editing-mediated exon evolution. Genome Biol. 2007, 8(2).
74. Lev-Maor G., et al. Intronic Alus influence alternative splicing. PLoS Genet. 2008, 4(9).
75. Lin L., et al. Diverse splicing patterns of exonized Alu elements in human tissues. PLoS Genet. 2008, 4(10).
76. Liston P., Fong W.G., Korneluk R.G. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 2003, 22(53):8568-8580.
77. Macfarlan T.S., et al. Endogenous retroviruses and neighboring genes are coordinately repressed by LSD1/KDM1A. Genes Dev. 2011, 25(6):594-607.
78. Mager D.L., et al. Endogenous retroviruses provide the primary polyadenylation signal for two new human genes (HHLA2 and HHLA3). Genomics 1999, 59(3):255-263.
79. Martinez-Garay I., et al. Intronic L1 insertion and F268S, novel mutations in RPS6KA3 (RSK2) causing Coffin-Lowry syndrome. Clin. Genet. 2003, 64(6):491-496.
80. McCallion A.S., Chakravarti A. EDNRB/EDN3 and Hirschsprung disease Type II. Pigment Cell Res. 2001, 14(3):161-169.
81. Medina M.W., Krauss R.M. The role of HMGCR alternative splicing in statin efficacy. Trends Cardiovasc. Med. 2009, 19(5):173-177.
82. Meischl C., et al. A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease. Eur. J. Hum. Genet. 2000, 8(9):697-703.
83. Miki Y., et al. Disruption of the Apc gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 1992, 52(3):643-645.
84. Miki Y., et al. Mutation analysis in the BRCA2 gene in primary breast cancers. Nat. Genet. 1996, 13(2):245-247.
85. Mine M., et al. A large genomic deletion in the PDHX gene caused by the retrotranspositional insertion of a full-length LINE-1 element. Hum. Mutat. 2007, 28(2):137-142.
86. Miriami E., Margalit H., Sperling R. Conserved sequence elements associated with exon skipping. Nucleic Acids Res. 2003, 31(7):1974-1983.
87. Mitchell G.A., et al. Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase: a role for Alu elements in human mutation. Proc. Natl. Acad. Sci. 1991, 88(3):815-819.
88. Mitchell G.A., et al. Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase - a role for Alu elements in human mutation. Proc. Natl. Acad. Sci. U. S. A. 1991, 88(3):815-819.
89. Mola G., et al. Exonization of Alu-generated splice variants in the survivin gene of human and non-human primates. J. Mol. Biol. 2007, 366(4):1055-1063.
90. Mukherjee S., et al. Molecular pathology of haemophilia B: identification of five novel mutations including a LINE 1 insertion in Indian patients. Haemophilia 2004, 10(3):259-263.
91. Muotri A.R., et al. The necessary junk: new functions for transposable elements. Hum. Mol. Genet. 2007, 16:R159-R167.
92. Narita N., et al. Insertion of a 5' truncated L1 element into the 3' end of exon-44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular-dystrophy. J. Clin. Investig. 1993, 91(5):1862-1867.
93. Neote K., et al. Structure and distribution of an Alu-type deletion mutation in Sandhoff disease. J. Clin. Investig. 1990, 86(5):1524-1531.
94. Nozell S., Chen X.B. p21B, a variant of p21(Waf1/Cip1), is induced by the p53 family. Oncogene 2002, 21(8):1285-1294.
95. Oldridge M., et al. De novo Alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am. J. Hum. Genet. 1999, 64(2):446-461.
96. Oricchio E., et al. Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene 2007, 26(29):4226-4233.
97. Pozner A., et al. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis. BMC Dev. Biol. 2007, 7:84.
98. Quelle D.E., et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995, 83(6):993-1000.
99. Ravindra T., Lakshmi N.K., Chaitanya K., Surender V., Ahuja Y.R. Clinical relevance of alternative splicing. Indian J. Hum. Genet. 2006, 12(2):45-52.
100. Ricci V., et al. An Alu-mediated rearrangement as cause of exon skipping in Hunter disease. Hum. Genet. 2003, 112(4):419-425.
101. Richards K.L., et al. Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability. PLoS One 2009, 4(3).
102. Sazani P., Kole R. Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. J. Clin. Investig. 2003, 112(4):481-486.
103. Schmitz J., Brosius J. Exonization of transposed elements: a challenge and opportunity for evolution. Biochimie 2011, 93(11):1928-1934.
104. Schulte A.M., et al. Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(25):14759-14764.
105. Schulz W.A., Steinhoff C., Florl A.R. Methylation of endogenous human retroelements in health and disease. DNA Methylation Dev. Genet. Dis. Cancer 2006, 310:211-250.
106. Schwahn U., et al. Positional cloning of the gene for X-linked retinitis pigmentosa 2. Nat. Genet. 1998, 19(4):327-332.
107. Shachter N.S. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr. Opin. Lipidol. 2001, 12(3):297-304.
108. Sironen A., et al. Infertile Finnish Yorkshire boars carry a full-length LINE-1 retrotransposon within the KPL2 gene. Mol. Gen. Genomics. 2007, 278(4):385-391.
109. Slotkin R.K., Martienssen R. Transposable elements and the epigenetic regulation of the genome. Nat. Rev. Genet. 2007, 8(4):272-285.
110. Sorek R. The birth of new exons: mechanisms and evolutionary consequences. RNA 2007, 13(10):1603-1608.
111. Sorek R., Ast G., Graur D. Alu-containing exons are alternatively spliced. Genome Res. 2002, 12(7):1060-1067.
112. Speek M. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol. Cell. Biol. 2001, 21(6):1973-1985.
113. Stamm S., et al. An alternative-exon database and its statistical analysis. DNA Cell Biol. 2000, 19(12):739-756.
114. Stone D.L., et al. Mutation of a gene encoding a putative chaperonin causes McKusick-Kaufman syndrome. Nat. Genet. 2000, 25(1):79-82.
115. Strathdee G., et al. Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy. Gynecol. Oncol. 2005, 97(3):898-903.
116. Sugimoto J., Schust D.J. Human endogenous retroviruses and the placenta. Reprod. Sci. 2009, 16(11):1023-1033.
117. Sun H., et al. MPromDb: an integrated resource for annotation and visualization of mammalian gene promoters and ChIP-chip experimental data. Nucleic Acids Res. 2006, 34:D98-D103.
118. Suzuki M.M., Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 2008, 9(6):465-476.
119. Sverdlov E.D. Perpetually mobile footprints of ancient infections in human genome. FEBS Lett. 1998, 428(1-2):1-6.
120. Sverdlov E.D. Retroviruses and primate evolution. Bioessays 2000, 22(2):161-171.
121. Takeda J., et al. H-DBAS: alternative splicing database of completely sequenced and manually annotated full-length cDNAs based on H-Invitational. Nucleic Acids Res. 2007, 35:D104-D109.
122. Tamura M., Kajikawa M., Okada N. Functional splice sites in a zebrafish LINE and their influence on zebrafish gene expression. Gene 2007, 390(1-2):221-231.
123. Taruscio D., Mantovani A. Factors regulating endogenous retroviral sequences in human and mouse. Cytogenet. Genome Res. 2004, 105(2-4):351-362.
124. Temtamy S.A., et al. Long interspersed nuclear element-1 (LINE1)-mediated deletion of EVC, EVC2, C4orf6, and STK32B in Ellis-van Creveld syndrome with borderline intelligence. Hum. Mutat. 2008, 29(7):931-938.
125. Tighe P.J., et al. Inactivation of the Fas gene by Alu insertion: retrotransposition in an intron causing splicing variation and autoimmune lymphoproliferative syndrome. Genes Immun. 2002, 3:S66-S70.
126. Tsuchiya M., et al. Association between endometriosis and genetic polymorphisms of the estradiol-synthesizing enzyme genes HSD17B1 and CYP19. Hum. Reprod. 2005, 20(4):974-978.
127. Umenishi F., Verkman A.S. Isolation and functional analysis of alternative promoters in the human aquaporin-4 water channel gene. Genomics 1998, 50(3):373-377.
128. van de Lagemaat L.N., et al. Transposable elements in mammals promote regulatory variation and diversification of genes with specialized functions. Trends Genet. 2003, 19(10):530-536.
129. Varon R., et al. Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome. Nat. Genet. 2003, 35(2):185-189.
130. Vervoort R., et al. A mutation (IVS8+0.6kbdelTC) creating a new donor splice site activates a cryptic exon in an Alu-element in intron 8 of the human beta-glucuronidase gene. Hum. Genet. 1998, 103(6):686-693.
131. Vidaud D., et al. Haemophilia B due to a de novo insertion of a human-specific Alu subfamily member within the coding region of the factor IX gene. Eur. J. Hum. Genet. 1993, 1(1):30-36.
132. Vitravene Study Group A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS. Am J. Ophthalmol. 2002, 133(4):467-474.
133. Wallace M.R., et al. A denovo Alu insertion results in neurofibromatosis type-1. Nature 1991, 353(6347):864-866.
134. Wang W., Kirkness E.F. Short interspersed elements (SINEs) are a major source of canine genomic diversity. Genome Res. 2005, 15(12):1798-1808.
135. Wang W., et al. Origin and evolution of new exons in rodents. Genome Res. 2005, 15(9):1258-1264.
136. Wheelan S.J., et al. Gene-breaking: a new paradigm for human retrotransposon-mediated gene evolution. Genome Res. 2005, 15(8):1073-1078.
137. Wicker T., et al. A unified classification system for eukaryotic transposable elements. Nat. Rev. Genet. 2007, 8(12):973-982.
138. Wilcox E.R., et al. Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell 2001, 104(1):165-172.
139. Winn V.D., et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology 2009, 150(1):452-462.
140. Yin H.F., Lu Q.L., Wood M. Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice. Mol. Ther. 2008, 16(1):38-45.
141. Yoshida K., et al. Insertional mutation by transposable element, L1, in the DMD gene results in X-linked dilated cardiomyopathy. Hum. Mol. Genet. 1998, 7(7):1129-1132.
142. Yu Y., et al. Dynamic regulation of alternative splicing by silencers that modulate 5' splice site competition. Cell 2008, 135(7):1224-1236.
143. Zarnack K., et al. Direct competition between hnRNP C and U2AF65 protects the transcriptome from the exonization of Alu elements. Cell 2013, 152(3):453-466.
144. Zhang X.H.F., Chasin L.A. Comparison of multiple vertebrate genomes reveals the birth and evolution of human exons. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(36):13427-13432.